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ORIGINAL ARTICLE
INTRODUCTION
Nutritional support is an essential part in
the management of hospitalized patients who are at
risk to develop undernutrition.1,2 It should be the aim of
every hospital to provide adequate nutrition to
the patients. Oral active intake is the most preferable
way to give nutrition; however, if oral intake is likely to
be absent for certain period of time (usually 5-7 days),
artificial nutrition support is needed in the form of
Enteral Tube Feeding (ETF). The most common form
of ETF is Nasogastric Tube (NGT) insertion. How-
ever, long-term NGT is usually avoided since it is
associated with nasal irritation, risk of displacement,
and cosmetically unacceptable.
Percutaneous Endoscopic Gastrostomy (PEG)
has been the most common method of enteral nutrition
in patients who require long-term tube feeding in the
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developed countries.3 It is used if enteral feeding is
likely to be needed for more than 4-6 weeks. PEG
insertion has been shown to improve morbidity and
mortality in patients with dysphagia due to acute stroke
and oropharyngeal cancers.4,5
PEG tube insertion is a relatively new procedure in
Indonesia with a few gastroenterologists currently
performing it in Jakarta. This technique requires a
special skill and training prior to be routinely done in
a gastroenterology practice. Clinical evaluation of PEG
procedure has not been done so far. This study was
aimed to evaluate clinical profile of patients underwent
PEG based on an early experience in a private hospital
in Jakarta.
METHOD
We studied the clinical profile of patients who
underwent PEG from 2000 to 2008 in Pondok Indah
hospital, Jakarta. Data were collected retrospectively
from the Medical Record Department and consisted
of age, gender, primary diagnosis, indication of PEG,
and other co-morbidities. Patients who died were also
recorded.
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Background: Percutaneous endoscopic gastrostomy (PEG) is only recently being introduced in
Indonesia with limited clinical experience. Clinical study of patients underwent PEG is very limited.
This study was aimed to evaluate clinical profile of patients underwent PEG in a private hospital in
Jakarta.
Method: A retrospective study was done to patients underwent PEG in Pondok Indah hospital, Jakarta
using medical record. Clinical data collected were patients’ demographics, diagnosis of underlying
disease, indication for PEG insertion, and follow-up visits.
Results: Ten cases were found between 2000 and 2008, six among them were men. All but one cases
aged more than 50 years. Ninety percents of the patients had cerebrovascular disorder as their primary
diagnosis and 60% of the main indication was dysphagia.
Conclusion: No procedure-related major complications and death has occurred. This procedure was
safe and potentially be offered to more widely clinical settings.
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The PEG procedure was performed at
the Endoscopy Unit under general anesthesia.
Gastrostomy tube (Wilson-Cook Medical Inc., USA)
was inserted by a pull-through method. A complete
esophagogastro-duodenoscopy was performed after
each PEG insertion. No antibiotic prophylaxis was
specially given to patients.
Patient was lying down at supine or left lateral
decubitus position. The head of the patient’s bed should
be at 30 degrees to reduce the risk of aspiration.
The posterior pharynx was anesthetized with a topical
anesthetic such as xylocaine. Afterwards,
the endoscope was inserted through the oropharynx to
the esophagus and stomach. Once the endoscope is in
the stomach, all of the residual fluid was suctioned to
prevent regurgitation and aspiration. Then, we
carefully observed the abdominal wall for any signs of
transillumination. At the time, another person palpated
the abdominal wall with his forefinger so that
the endoscopist could visualize a potential entry site.
Once an appropriate PEG entry site was identified,
the abdomen is cleansed with an antiseptic. The patient’s
abdomen was covered with a sterile drape containing
a hole in the middle that is positioned over the PEG
entry site. A safe gastric access entry site was then
established by using a 22-gauge needle. Then,
the abdominal skin was anesthetized using 3-5 mL
lidocaine intradermally to raise a skin “wheal”. At this
place, an incision of about 1 cm was made vertically or
horizontally with a scalpel. Following the incision,
a needle catheter from the commercial PEG kit was
passed into the gastric cavity. Once the needle
catheter is in the stomach, it is snared by
the endoscopist. The inner needle was removed,
leaving the plastic outer sheath in the gastric cavity.
A guidewire was threaded through the plastic sheath
into the gastric cavity. Finally, the guidewire is snared,
pulled out of the mouth with the endoscope, and
released from the snare.
RESULTS
Ten patients underwent PEG tube insertion was
assessed in this study, comprising 6 men and 4 women.
The patients’ median age was 72.5 years;
the youngest patient was 17 years old. Other patients
aged more than 50 years (table 1).
Almost all patients had cerebrovascular disorder as
the primary diagnosis or underlying condition. The most
common indication of PEG insertion was dysphagia.
Hypoalbuminemia was noted in one patient, but many
cases do not have records on albumin level. Several
comorbidities was found, mostly involved the neuro-
muscular system. One patient (the youngest) has been
diagnosed with hydrocephalus since his infancy (table
2). There was no case of oropharyngeal or esophageal
malignancy.
Table 1. Characteristics of patients underwent PEG  
 Characteristic n % 
Sex   
 Male 6 60 
 Female 4 40 
Age (years)   
< 50  1 10 
51 – 60  2 20 
61 – 70  2 20 
71 – 80  3 30 
> 80  2 20 
 
Table 2. Primary diagnosis, indication, and other  
co-morbidities of patients underwent PEG  
Variable n % 
Primary diagnosis   
 Stroke 9 90 
 Hydrocephalus 1 10 
Main indication for PEG   
 Dysphagia 6 60 
 Vomiting 1 10 
 Malnutrition 3 30 
Co-morbidities    
 None 5 50 
 Chronic obstructive lung disease 1 10 
 Bell’s palsy 1 10 
 Alzheimer’s disease 1 10 
 Parkinsonism and hydrocephalus 1 10 
 Congenital hydrocephalus 1 10 
 
A few patients needed PEG tube reposition within
30 days of first insertion and minimal bleeding was
observed in one patient. No infection was found in
the site of PEG tube insertion (peristomal infection) or
along the upper gastrointestinal tract. There was no
procedure-related major complication or death. Two
patients died due to their underlying disease. PEG
insertion is aimed for long-term enteral nutrition.
Permanent removal of PEG tube is recommended
Figure 1. Incision of the abdominal wall
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whenever the patient’s oral intake function has returned
to normal. PEG tube removal and re-insertion was done
at an interval of 3 to 6 months. This was done without
general anesthesia.
DISCUSSION
There are several indications for PEG tube
placement i.e. neurological disorders of swallowing,
cognitive impairment and depressed consciousness,
mechanical obstruction to swallowing and long-term
partial failure of intestinal function requiring
supplementary intake.6 Our data show that the most
common indication for PEG procedure was dysphagia
due to stroke. There was a patient with dementia
(Alzheimer’s disease). One patient also had
hypoalbuminemia prior to PEG placement.
Cerebrovascular disease was accounted for 60.4%
of 181 cases of PEG in Singaporean study. Other
indications were Parkinson’s disease and other
neuromuscular disorders in 10.9% cases, naso-
pharyngeal carcinoma and upper gastrointestinal
malignancies in 24.7%, and head injury in 4%.7
A retrospective study in 198 patients who underwent
PEG showed that cerebrovascular disorder was also
the most common primary diagnosis (75.3%) with
a median age of 78 years (25-97 years). Alzheimer
was found in 19 cases and hydrocephalus only two
cases. That study also found high mortality rate;
survival was decreasing from 84.7% at 1 month to
52.6% at 6 months, 38.1% at 1 year, 27.8% at 2 years,
and 22.3% at 3 years. Pneumonia was the most
common cause of death. Independent predictors of
mortality were a low serum albumin concentration
(≤ 2.9 g/dL) and history of pneumonia before
the procedure.8
PEG procedure is occasionally offered to patients
with dementia in hoping that it would improve their
survival. Recent study concluded that demented
patients were not associated with poorer survival after
PEG compared to non-demented patients. However,
in elderly patients, male gender, advanced age (> 80
years), hypoalbuminemia (< 2.8 g/dL), chronic heart
failure, and previous subtotal gastrectomy were
predictors of poor survival.9
In this series, PEG procedure was mainly
offered to patients with cerebrovascular disorders since
it is the most common condition that would need
longterm enteral access. Moreover, our hospital is not
an academic referral hospital which usually had more
various medical conditions. Theoretically, PEG was not
mainly indicated for enteral feeding only, but also for
gut decompression in case of advanced abdominal
malignancies causing chronic obstruction or ileus.10
PEG tube insertion is contraindicated when there is
pharyngeal or esophageal obstruction, active
coagulopathy and other contraindication to
endoscopy.11
At this moment, we do not routinely give
antibiotic prophylaxis before PEG since many patients
had received some antibiotics for their illness.
Meta-analysis and randomized control trial supported
the use of antibiotic prophylaxis before PEG tube
insertion to reduce peristomal infection.12,13
The antibiotic used for prophylaxis may vary such as
cephalosporins, quinolones, macrolides and others.
Ciprofloxacin and cloxacillin were used in
the Singaporean study,7 while others have used
cefuroxime.13 Recently, PEG site infections caused by
methicillin-resistant Staphylococcus aureus has been
reported and warrants further study on the adequacy
of prophylactic antibiotic recommendation.14
CONCLUSION
Percutaneous endoscopic gastrostomy has
increasingly gain acceptance as an alternative
strategy for long-term enteral access in Pondok Indah
hospital. The main indication for PEG tube insertion is
dysphagia to cerebrovascular accident. Procedure-
related complications were low and no death due to
Figure 2. Insertion of the PEG tube
Figure 3. Placement of PEG in the gastric cavity
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this procedure. PEG procedure was safe and could
potentially be offered to more patients in wider clinical
settings.
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